National Healthcare Quality Report, 2006: Table 2.40

You Are Here: AHRQ Home > Quality & Patient Safety > Measuring Healthcare Quality > National Healthcare Quality Report, 2006

Table 2.40
Percent of patients with adverse drug events: anticoagulant related low molecular weight heparin and factor Xa, United States, 2004^a
		2004
Population group		Exposed	Adverse events	Percent	Standard error
Total		4,649	449	9.7	0.4
Age	Under 65	620	51	8.2	1.1
	65-74	1,497	123	8.2	0.7
	75-84	1,751	189	10.8	0.7
	85 and over	781	86	11.0	1.1
Gender	Female	2,707	252	9.3	0.6
Gender	Male	1,942	197	10.1	0.7
Race	Black	449	49	10.9	1.5
	Other	223	15	6.7	1.7
	White	3,977	385	9.7	0.5
Diabetes	No	3,083	296	9.6	0.5
Diabetes	Yes	1,566	153	9.8	0.8
Obesity	No	3,942	382	9.7	0.5
Obesity	Yes	707	67	9.5	1.1
Cerebrovascular disease	No	3,547	331	9.3	0.5
Cerebrovascular disease	Yes	1,102	118	10.7	0.9
CHF/pulmonary edema	No	2,994	251	8.4	0.5
CHF/pulmonary edema	Yes	1,655	198	12.0	0.8
COPD	No	3,077	280	9.1	0.5
COPD	Yes	1,572	169	10.8	0.8
Smoking	No	3,968	382	9.6	0.5
Smoking	Yes	681	67	9.8	1.1
Cancer	No	3,550	316	8.9	0.5
Cancer	Yes	1,099	133	12.1	1.0
Corticosteroids	No	4,290	409	9.5	0.4
Corticosteroids	Yes	359	40	11.1	1.7
Coronary artery disease	No	2,202	187	8.5	0.6
Coronary artery disease	Yes	2,447	262	10.7	0.6
Renal disease	No	3,620	293	8.1	0.5
Renal disease	Yes	1,029	156	15.2	1.1

^a Data include Medicare beneficiaries discharged from January to December. Readmissions are supposed to be counted in the numerators according to the measure specifications, but were not counted because the data were not available at this time.

Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease.

Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System.

Return to Contents